Van der Niepen P, Dupont A G, Finne E, Six R O
Department of Pharmacology, University of Brussels, Belgium.
J Hypertens Suppl. 1988 Dec;6(4):S687-9. doi: 10.1097/00004872-198812040-00216.
The effects of systemic administration of the selective dopamine1 receptor agonist fenoldopam and the selective dopamine2 receptor agonist quinpirole on blood pressure and regional haemodynamics were investigated in anaesthetized normotensive Wistar rats. Both compounds produced dose-dependent reductions in blood pressure. Mesenteric and renal blood flow were enhanced by fenoldopam, but reduced by quinpirole. Hindquarter blood flow was not modified by fenoldopam, but was increased by quinpirole. The calculated vascular resistances were reduced by both compounds in the three vascular beds. The effects of fenoldopam were antagonized by SCH 23390 but SCH 23390 did not affect those of quinpirole. The effects of quinpirole, but not those of fenoldopam, were antagonized by domperidone. Hexamethonium abolished the effects of quinpirole without affecting those of fenoldopam. These results indicate that the hypotensive effects of fenoldopam and quinpirole are due to stimulation of postsynaptic dopamine1 and neuronal dopamine2 receptors, respectively, resulting in differential regional haemodynamic effects.
在麻醉的正常血压Wistar大鼠中,研究了选择性多巴胺1受体激动剂非诺多泮和选择性多巴胺2受体激动剂喹吡罗全身给药对血压和局部血流动力学的影响。两种化合物均产生剂量依赖性的血压降低。非诺多泮可增强肠系膜和肾血流量,但喹吡罗可使其减少。非诺多泮对后肢血流量无影响,但喹吡罗可使其增加。两种化合物均可降低三个血管床的计算血管阻力。SCH 23390可拮抗非诺多泮的作用,但不影响喹吡罗的作用。多潘立酮可拮抗喹吡罗的作用,但不影响非诺多泮的作用。六甲铵可消除喹吡罗的作用,而不影响非诺多泮的作用。这些结果表明,非诺多泮和喹吡罗的降压作用分别是由于刺激突触后多巴胺1受体和神经元多巴胺2受体,从而导致不同的局部血流动力学效应。